Pharm Company: * NEXGEN PHARMA INC
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Asenapine Overview

Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder. It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.[5] Contents 1 Medical uses 1.1 Schizophrenia 1.2 Acute mania 2 Adverse effects 2.1 Discontinuation 3 Pharmacology 3.1 Pharmacodynamics 4 History 5 References ...

Read more Asenapine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Asenapine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • System: 3.8mg/24hr, 5.7mg/24hr, 7.6mg/24hr
  • Tablet: 10mg, 2.5, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Asenapine: (3 results)

Sorted by National Drug Code
  • 59762-1091 Asenapine 2.5 mg Sublingual Tablet by Greenstone LLC
  • 59762-2012 Asenapine 5 mg Sublingual Tablet by Greenstone LLC
  • 59762-2888 Asenapine 10 mg Sublingual Tablet by Greenstone LLC

Other drugs which contain Asenapine or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 30 September 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA